## Critical Parameters Checklist (from the protocol)

- Temperatures: 37°C incubation for bacterial growth and mouse model; 43°C non-permissive temperature for plasmid integration; 55°C for pigment extraction step
- Times:  
  - Overnight growth on TSA plates: 24 h  
  - Planktonic cultures: variable sampling at 2, 6, 12 h  
  - Induction of second recombination event: 3–5 days with periodic subcultures every 24 h  
  - Hydrogen peroxide treatment: 2 h  
  - DAF-FM staining: 1 h incubation, fluorescence measured after 30–90 min  
  - Pigment extraction: vortex 10 s, incubation 5 min at 55°C  
  - Murine infection monitoring: 7 days or until pre-moribund state  
- Volumes:  
  - Glycerol stocks: 1:1 mixing of culture and 50% glycerol  
  - 1 ml aliquots used for suspensions for pigment assays, phenylalanine biosynthesis inocula, and other measurements  
  - 200 µl aliquots used for fluorescence plate assays in 96-well plates  
  - Plate volumes: 96-well plates for growth assays and fluorescence readings  
- Concentrations:  
  - Antibiotics: chloramphenicol 2, 5, or 10 mg/ml; erythromycin 2 or 10 mg/ml; ampicillin 50 mg/ml; kanamycin 50 mg/ml  
  - Hydrogen peroxide: 250 mM for oxidative stress assays  
  - DAF-FM diacetate: 5 mM staining concentration  
  - DEA/NO and DEA controls: 100 mM  
  - cPTIO (NO scavenger): 150 mM  
- rpm/RCF:  
  - Aerobic planktonic culture: 250 rpm  
  - Low-oxygen static culture: 0 rpm  
  - Centrifugation: 13,000 rpm for 2–3 min for cell harvesting and washing steps  
- CO2/O2:  
  - Aerobic conditions (~air levels O2) with shaking (250 rpm)  
  - Low-oxygen defined as static culture with increased volume-to-flask ratio (7:10 volume-to-flask), no shaking (0 rpm)  
- Mouse infections: 1 × 10^8 CFU per mouse via tail vein injection (100 µl of 1 × 10^9 CFU/ml suspension); n=9 mice per group  

## Potential Missing Parameters (compare to source)

- Exact flask sizes or volumes for planktonic cultures are not specified beyond volume-to-flask ratios; no flask volume given (source says 1:10 or 7:10 volume-to-flask ratio but no flask absolute volumes detailed)  
- Temperature of centrifugation steps (likely room temperature but not explicitly stated)  
- Specific source or detailed composition of chemically defined media (CDM) used, only generally referenced from literature  
- No explicit details in protocol for CHROMATOGRAPHIC or other methods used for metabolite confirmation (phenylpyruvate, etc.) [CHECK] (likely not in source)  
- Details of PCR cycling parameters, enzyme concentrations, and thermocycler conditions omitted  
- Details of mouse housing environment (temperature, humidity, light-dark cycles) are omitted but only broadly referenced as standard conditions  
- Exact OD600 values used to initiate some experiments (e.g., H2O2 assays are mid-exponential phase but exact OD range not specified beyond approximate 0.5 in source)  
- No explicit information on incubation times during phage transduction or electroporation efficiencies—assumed standard  
- The fluorescence measurement intervals and specifics of fluorimeter settings (gain, sensitivity) not exhaustively listed (except EX/EM wavelengths)  
- The sequence or source of primers (sequences provided in source but not in protocol)  

## Possible Hallucinations / Unsupported Claims

- None detected.  
- The generated protocol does not add unsubstantiated claims or steps; all protocol sections are supported by detailed descriptions in the source text.  
- Interpretation statements (e.g., "saNOS is not required for activity of saPDT") are omitted from protocol and only present in discussion, which is appropriate.  

## Step Order / Omission Risks

- No major step order changes apparent; protocol follows source descriptions for mutant creation, growth assays, complementation, RNA work, and mouse model.  
- The use of RNAse-free conditions and rigorous RNA QC (e.g., RIN values) is not explicitly stated but typically implied; possible risk if omitted.  
- The protocol simplifies detailed screening and confirmation assays (Southern blotting, PCR screening) to brief steps—may risk skipping confirmation details if blindly followed.  
- The timing and temperature conditions during plasmid integration and excision steps in mutant construction appear consistent with source.  
- DAF-FM staining steps are appropriately detailed, though details about photobleaching avoidance during fluorescence measurement are not discussed—[CHECK].  
- Because partial polarity of nos::erm insertion mutant onto pdt is noted in source, the use of complemented strains is important; the protocol includes these but does not explicitly caution about this phenomenon—should be flagged as potential risk for experimenter.  
- The growth assays in chemically defined media use static conditions in microplates per source, which the protocol reflects; no oxygen control other than static conditions—possible variability in low-oxygen condition control if not carefully monitored—[CHECK].  

# Summary

The generated protocol accurately reflects the detailed experimental procedures, conditions, and parameters described in the source text. The critical numeric parameters such as temperature, time, media conditions, antibiotic concentrations, rpm, and fluorescence measurement settings are all well covered. Minor potential omissions pertain to some procedural details standard in molecular biology work but not always specified in source, including exact flask volumes during TSB growth, PCR thermocycling parameters, centrifugation temperatures, and mouse housing details. No unsupported or hallucinated claims are included in the protocol, which attentively sticks to methods present in the source. Slight caution is advised regarding the partial polar effect of the nos mutation on pdt expression, and the necessity of complementation controls to confirm phenotypes. Overall, the protocol is trustworthy with minor points for confirmation and attention during execution.